Cancer treatment company Biontech raised $325m round backed by Fidelity. The company forms part of the hopeful oncology and cancer treatment subsector of life sciences which has seen much growth and in corporate backing in recent years.
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Tal Education Group, which contributed to Minerva’s series B round five years ago, has returned for a series C led by Bytedance.
Node is developing artificial intelligence technology that helps companies identify business opportunities and has raised $16m from MS&AD, JetBlue and others.
Returning investor Singtel Innov8 took part in the round together with Kickstart Ventures, allowing Igloohome to bolster its research and development budget.
Visa has contributed to a $40m series B round for Anchorage, which is working on cryptocurrency protection technology that does not require a password.
Intel Capital has led a consortium that also featured UL Ventures to inject $20m into Kyndi.
Leapstack Data Technology will put the money from the PPDAI Group-backed $14.5m round to partner additional insurance companies in China.
Fidelity Management & Research has led a $325m series B round for Biontech, a spinout of Johannes Gutenberg University Mainz whose backers also include Sanofi and Pfizer.
Tencent has contributed to a $35m series B round for Niyo Solutions, the operator of a mobile bank that gives blue collar workers access to financial services.